Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe
12 mars 2024 06h00 HE
|
Greenwich LifeSciences, Inc.
STAFFORD, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,...